CURATED HEALTH UPDATES
Resurgence of Sexually Transmitted Diseases in the US During the Pandemic

The relentless momentum of the STD epidemic continued during the COVID-19 pandemic, with disruptions in healthcare services exacerbating the spread of sexually transmitted infections, underscoring the need for comprehensive prevention and control measures.

December 2022

WHO Recommends Nirmatrelvir and Ritonavir for Non-
WHO Recommends Nirmatrelvir and Ritonavir for Non-Severe COVID-19 Cases

The World Health Organization (WHO) recommends the use of nirmatrelvir and ritonavir for non-severe COVID-19 cases, citing their potential to reduce hospitalizations and alleviate disease burden in affected individuals.

December 2022

Pheochromocytoma: Clinical Presentation and Management

Pheochromocytoma can present with the classic triad of headache, palpitations, and sweating, and timely diagnosis and management are crucial to prevent potentially life-threatening complications associated with excessive catecholamine release.

December 2022

SARS-CoV-2 Variants and Long COVID: Insights into
SARS-CoV-2 Variants and Long COVID: Insights into Clinical Phenotypes

An Italian study of patients with long COVID suggests the existence of different clinical phenotypes associated with SARS-CoV-2 variants, highlighting the complexity of post-acute sequelae and the need for tailored management approaches to address diverse symptom profiles.

December 2022

Predictive Markers for Fatty Liver Disease and Ass
Predictive Markers for Fatty Liver Disease and Associated Metabolic Conditions

Fatty liver disease is associated with various metabolic disorders, including type 2 diabetes and cardiovascular diseases, underscoring the importance of identifying predictive markers to facilitate early intervention and risk stratification.

December 2022

Long COVID Affects 30% of Patients With Persistent
Long COVID Affects 30% of Patients With Persistent Symptoms

Long COVID, characterized by persistent symptoms following acute infection, affects approximately 30% of individuals, highlighting the need for improved diagnostic tools and targeted interventions to address long-term sequelae of COVID-19.

December 2022

Treatment of Antibiotic-Resistant Gram-Negative Infections: Focus on Key Pathogens

A comprehensive review focuses on the treatment of infections caused by antibiotic-resistant Gram-negative bacteria, including AmpC-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia, highlighting therapeutic challenges and strategies.

December 2022

Fatigue Prevalent Among Adults With Inflammatory Bowel Disease

Fatigue is highly prevalent among adults with inflammatory bowel disease, underscoring the significant impact of chronic illness on overall quality of life and the importance of comprehensive management strategies to address fatigue-related disability.

December 2022

Respiratory Syncytial Virus: Over 100,000 Deaths W
Respiratory Syncytial Virus: Over 100,000 Deaths Worldwide

Respiratory Syncytial Virus (RSV) contributes to over 100,000 deaths globally, with nearly half of these deaths occurring in children under six months of age, highlighting the need for effective prevention and management strategies, particularly in vulnerable populations.

December 2022

FDA Approves First COVID Breath Test for Rapid Dia
FDA Approves First COVID Breath Test for Rapid Diagnosis

The FDA approves the first COVID breath test for rapid diagnosis, following validation studies demonstrating its performance in detecting SARS-CoV-2 infection in individuals with and without symptoms.

December 2022